← 產業報告目錄
Curative Therapeutics Market Size, Share & Trends Analysis Report by Type (Biology Modifying Drugs, Gene Therapies, Cell Therapies), By Indication (Cancer, Musculoskeletal Disorders, Neurodegenerative Diseases, Rare Diseases, Hepatitis C, Others), By End User (Pharmaceutical Companies, Academic & Research Institutions, Others), Region and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-28頁數 180報告編號 INSIGHTACE-0b359c1ac4
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Curative Therapeutics Market is poised to increase at a compound annual growth rate of 7.8% throughout the 2025–2034 forecast period.
Curative Therapeutics covers medical treatments that aim to provide a permanent cure for a particular disease or condition. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is propelled by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Curative Therapeutics Market Snapshot
Chapter 4. Global Curative Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Biology Modifying Drugs
5.2.2. Gene Therapies
5.2.3. Cell Therapies
Chapter 6. Market Segmentation 2: By Indication Estimates & Trend Analysis
6.1. By Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Indication:
6.2.1. Cancer
6.2.2. Musculoskeletal Disorders
6.2.3. Neurodegenerative Diseases
6.2.4. Rare Diseases
6.2.5. Hepatitis C
6.2.6. Others
Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis
7.1. By Type & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-User:
7.2.1.1. Pharmaceutical Companies
7.2.1.2. Academic & Research Institutions
7.2.1.3. Others
Chapter 8. Curative Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Curative Therapeutics Market Revenue (US$ Million) Estimates and forecasts By Type, 2021-2034
8.1.2. North America Curative Therapeutics Market Revenue (US$ Million) Estimates and Forecasts By Indication, 2021-2034
8.1.3. North America Curative Therapeutics Market Revenue (US$ Million) Estimates and forecasts By End-User, 2021-2034
8.1.4. North America Curative Therapeutics Market Revenue (US$ Million) Estimates and forecasts by Country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Curative Therapeutics Market Revenue (US$ Million) by Type, 2021-2034
8.2.2. Europe Curative Therapeutics Market Revenue (US$ Million) Estimates and Forecasts By Indication, 2021-2034
8.2.3. Europe Curative Therapeutics Market Revenue (US$ Million) Estimates and forecasts By End-User, 2021-2034
8.2.4. Europe Curative Therapeutics Market Revenue (US$ Million) by Country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Curative Therapeutics Market Revenue (US$ Million) by Type, 2021-2034
8.3.2. Asia Pacific Curative Therapeutics Market revenue (US$ Million) Estimates and Forecasts By Indication, 2021-2034
8.3.3. Asia Pacific Curative Therapeutics Market revenue (US$ Million) Estimates and Forecasts By End-User, 2021-2034
8.3.4. Asia Pacific Curative Therapeutics Market Revenue (US$ Million) by Country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Curative Therapeutics Market revenue (US$ Million) by Type, 2021-2034
8.4.2. Latin America Curative Therapeutics Market Revenue (US$ Million) Estimates and Forecasts By Indication, 2021-2034
8.4.3. Latin America Curative Therapeutics Market Revenue (US$ Million) Estimates and Forecasts By End-User, 2021-2034
8.4.4. Latin America Curative Therapeutics Market revenue (US$ Million) by Country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Curative Therapeutics Market revenue (US$ Million) by Type, (US$ Million)
8.5.2. Middle East & Africa Curative Therapeutics Market Revenue (US$ Million) Estimates and Forecasts By Indication, 2021-2034
8.5.3. Middle East & Africa Curative Therapeutics Market Revenue (US$ Million) Estimates and forecasts By End-User, 2021-2034
8.5.4. Middle East & Africa Curative Therapeutics Market Revenue (US$ Million) by Country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Pfizer, Inc.,
9.2.2. GlaxoSmithKline plc.,
9.2.3. Sanofi S.A. (Genzyme-Voyager Therapeutics),
9.2.4. bluebird bio, Inc.,
9.2.5. Novartis International AG,
9.2.6. Spark Therapeutics, Inc.,
9.2.7. Kite Pharma Inc.,
9.2.8. Gilead Sciences, Inc.,
9.2.9. Others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們